Clinical trials for Prostate cancer

138 currently recruiting clinical trials
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05875168 #2023-507937-14-00
Locally Advanced Metastatic Metastatic Castration-resistant 1 2 3 or more
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Hôpital de la Timone AP-HM (Marseille), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
Daiichi Sankyo
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05410145 #2023-508517-16-00
Locally Advanced Metastatic Metastatic Castration-resistant KRAS G12C 1 2 3 or more
Systemic Treatment-Naive
CHU - Haut-Lévêque - Bordeaux (Pessac), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon)
D3 Bio (Wuxi) Co., Ltd
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B1
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif)
Artios Pharma Ltd
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B4
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif)
Artios Pharma Ltd
Phase 1 / Phase 2 Prostate cancer #NCT07190300 #2025-521873-15-00
Adenocarcinoma Metastatic Hormone-sensitive None Hormone therapy Hormone therapy
Internal Vectorised Radiotherapy (IVR)
Hôpital Henri-Mondor AP-HP (Créteil)
Novartis
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06128551
Phase 1b extension de dose et phase 2 cohortes tumeurs solides naïves d'inhibiteurs de KRAS G12C
Locally Advanced Metastatic Metastatic Castration-resistant KRAS G12C 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron ), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille) (and 2 more...)
Revolution Medicines, Inc.
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06128551
Phase 1b Escalade de dose
Locally Advanced Metastatic Metastatic Castration-resistant KRAS G12C 1 2 3 or more
Systemic Treatment-Naive
Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron ), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille) (and 2 more...)
Revolution Medicines, Inc.
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05768139 #2023-000442-41
Cohortes monothérapie (partie 1)
HR Positive Locally Advanced Metastatic PIK3CA 1 2 3 or more
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), IUCT Oncopôle (Toulouse), IUCT Oncopôle (Toulouse)
Eli Lilly et compagnie
Phase 1 / Phase 2 Prostate cancer #NCT07206056 #2025-521880-10-00
Adenocarcinoma Metastatic Castration-resistant 1 2 3 or more Hormone therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris), Institut Bergonié (Bordeaux)
Novartis
Phase 1 / Phase 2 Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06726148 #2024-517281-42-00
Phase I - cancer amplifié CCNE1
Locally Advanced Metastatic Other mutation 1 2 3 or more
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Institut Bergonié (Bordeaux)
Novartis